A detailed history of Mc Ilrath & Eck, LLC transactions in Cybin Inc. stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 400 shares of CYBN stock, worth $4,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 400 -0.0%
Holding current value
$4,992
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$1.83 - $3.18 $732 - $1,272
400 New
400 $1,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $2.07B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Mc Ilrath & Eck, LLC Portfolio

Follow Mc Ilrath & Eck, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.